[SH:1][CH2:2][C:3]([O:5]C)=[O:4].[Cl:7][C:8]1[C:9]([F:33])=[N:10][C:11](NCC(OC)=O)=[C:12]([Cl:26])[C:13]=1[O:14][C:15]1[CH:20]=[CH:19][C:18]([O:21]C)=[C:17]([CH:23]([CH3:25])[CH3:24])[CH:16]=1>>[Cl:7][C:8]1[C:9]([F:33])=[N:10][C:11]([S:1][CH2:2][C:3]([OH:5])=[O:4])=[C:12]([Cl:26])[C:13]=1[O:14][C:15]1[CH:20]=[CH:19][C:18]([OH:21])=[C:17]([CH:23]([CH3:25])[CH3:24])[CH:16]=1By use of methyl mercaptoacetate in place of glycine methyl ester for the preparation of Compound 1e followed by deprotection as described for example 2.
読み込み中…